MAPT and Alzheimer disease: In a future study, we will build on these findings by examining the effects of lomerizine on AD pathology (Aβ accumulation as well as tau) in mouse models of AD (e.g., Aβ-overexpressing 5xFAD mice or tau Tg PS19 mice).